BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34898336)

  • 1. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
    Mahjoub H; Loya A; Ayaz T; Weng CY
    Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary malignancies after ocular adnexal lymphoma diagnosis.
    Loya A; Ramachandran V; Ayaz T; Weng CY
    BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
    Loya A; Gombos DS; Patel SP
    Front Oncol; 2022; 12():853076. PubMed ID: 35372013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study.
    Beroukhim K; Pourang A; Eisen DB
    J Am Acad Dermatol; 2020 Mar; 82(3):683-689. PubMed ID: 31626886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
    Yang Z; Liu L; Leng K; Shi G
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.
    Borghi A; Corazza M; Chiaranda G; Michiara M; Mangone L; Caruso B; Falcini F; Maestri I; Ferretti S
    Cancer Epidemiol; 2019 Aug; 61():176-184. PubMed ID: 31301588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
    Jung GW; Dover DC; Salopek TG
    Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between ocular melanoma and other primary cancers: an international population-based study.
    Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
    Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective.
    Guzzinati S; Buja A; Grotto G; Zorzi M; Manfredi M; Bovo E; Del Fiore P; Tropea S; Dall'Olmo L; Rossi CR; Mocellin S; Rugge M
    Front Public Health; 2023; 11():1195458. PubMed ID: 37397750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.
    Alfaar AS; Saad AM; KhalafAllah MT; Elsherif OE; Osman MH; Strauß O
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):515-526. PubMed ID: 32870371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
    Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S
    J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.
    Hussain Z; Khan J; Saeed A; Dihowm F
    Cancer Diagn Progn; 2021; 1(5):393-398. PubMed ID: 35403153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.